PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
8,50 $
0,00%
(0,00) 1D
12 հոկ, 10:22:09 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTKFY...
Mkt. cap
30,19 տրլն
Avg. vol.
1,94 հզր
Volume
1,43 հզր
52-wk high
16,36 $
52-wk low
7,63 $
Beta
0,09
Shares outstanding
234,07 մլն
No. of employees
13 հզր
Mkt. cap
30,19 տրլն
Avg. vol.
1,94 հզր
Volume
1,43 հզր
52-wk high
16,36 $
52-wk low
7,63 $
Beta
0,09
Shares outstanding
234,07 մլն
No. of employees
13 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
59 րոպե առաջ
Kalbe Farma cancels IDR 500 billion buyback for Kalbe Farma stock
ad-hoc-news.de
·
1 ժամ առաջ
Kalbe Farma stock pre-market ahead of the Xetra open
ad-hoc-news.de
·
16 ժամ առաջ
Kalbe Farma reports 6,000 health packages while Kalbe Farma stock trades at EUR 0.03
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About PT Kalbe Farma Unsponsored Indonesia ADR